Sergio Rodriguez

433 citations
21 papers · 302 indexed · h-index 10

Sergio Rodriguez

21 papers receiving 297 citations

Peers

Sergio Rodriguez
Comparison fields: 5 of 70
  • Nephrology 107
  • Hepatology 30
  • Epidemiology 72
  • Emergency Medicine 19
  • Microbiology 10
Replace Mohammad Ali Amirzargar with:
Mohammad Ali Amirzargar Iran
Paola Boni Italy
Thomas Johnston United States
Johnnie Oli Nigeria
W Siede Germany
N. Rekik Tunisia
Abdülmecit Yıldız Türkiye
Samantha Downie United Kingdom
Achilleas Attilakos Greece
Devin Steenkamp United States
Sergio Rodriguez relative to Mohammad Ali Amirzargar Iran Mohammad Ali Amirzargar's profile →
Citations per field
00.5×5.3×
Mohammad Ali Amirzargar · 1×
Citations per year

Countries citing papers authored by Sergio Rodriguez

Since Specialization
Citations

This map shows the geographic impact of Sergio Rodriguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Rodriguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Rodriguez more than expected).

Fields of papers citing papers by Sergio Rodriguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Rodriguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Rodriguez. The network helps show where Sergio Rodriguez may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sergio Rodriguez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sergio Rodriguez Line = papers co-authored together Sergio Rodriguez links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 20231
3 20222
4 202233
5 20211
6 202044
7 201918
8 20196
9 20193
10 201914
11 20186
12 20184
13 20174
14 201740
15 201618
16 20161
17 201626
18 201422
19 200924
20 200631

About Sergio Rodriguez

Sergio Rodriguez is a scholar working on Nephrology, Hepatology and Epidemiology, having authored 21 papers that have together received 302 indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (7 papers), Liver Disease Diagnosis and Treatment (5 papers), Genetic Syndromes and Imprinting (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Organ Transplantation Techniques and Outcomes (3 papers), Blood properties and coagulation (2 papers), Fibroblast Growth Factor Research (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Nephrology (107 citations), Hepatology (30 citations) and Epidemiology (72 citations). Sergio Rodriguez has collaborated with scholars based in Spain, United States and Guatemala. Frequent co-authors include Nayra Pérez‐Delgado, Carmen Mora‐Fernández, Carla Ferri, Javier Donate‐Correa, Ernesto Martín‐Núñez, Carolina Hernández-Carballo, Juan F. Navarro‐González, Leonardo Lorente, Alejandro Jiménez and Víctor G. Tagua. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026